During the past decade, Ospedale Bellaria conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Bellaria" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials, followed by "Istituto Oncologico Veneto IRCCS" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "GenSight Biologics" with 2 trials sponsored and "Gruppo di Ricerca GISSI" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Bellaria" #1 collaborator was "NCIC Clinical Trials Group" with 3 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator, "BAYER S.p.A. - Italia" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Bellaria" are "Brain and Central Nervous System Tumors" (4 trials), "Breast Cancer" (3 trials), "Glioblastoma Multiforme" (2 trials), "Leber Hereditary Optic Neuropathy" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Ospedale Bellaria" in a lesser frequency.

Most popular intervention types in "Ospedale Bellaria" are "Drug" (26 trials), "Other" (3 trials), "Radiation" (3 trials), "Device" (2 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "radiation therapy" (3 trials), "temozolomide" (3 trials), "Erlotinib" (2 trials) and "Pemigatinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Bellaria" are 31 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Bellaria". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Ospedale Bellaria, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Bellaria, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".